Patent · US Active

Allergen dosage form

US10080719B2 · kind B2 · utility

4Cited by
12References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 6, 2016
Grant dateSep 25, 2018
Priority date
Expiry dateJul 6, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides allergen containing pharmaceutical products and in particular fast-dispersing solid allergen dosage forms. In particular, fast-dispersing, non-compressed solid dosage forms suitable for oromucosal administration comprising a matrix and at least one allergen are provided. Suitable matrices are gelatine, starch and mannitol. Methods for the dosage forms are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.